Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Amerise Biosciences Annual General Meeting

Amerise Biosciences Limited conducted its 41st Annual General Meeting on September 24, 2026. Shareholders approved financial statements and the appointment of a new Wholetime Director and CFO.

Source

BSE filing, NSE: AMARDEE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Amerise Biosciences Ltd: key numbers

Share price
₹0.82
Market cap
₹5.42 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹0.02 Cr
P/E (TTM)
-102.6×Sector 26.2×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Amerise Biosciences Ltd

All →

Other annual general meeting announcements

All →